Agilux implements Thermo Watson LIMS for bioanalytical services

Agilux Laboratories, a provider of pharmaceutical and biotech services, today announced that it has completed the validation and implementation of the Thermo Watson Laboratory Information Management System (LIMS) for the company's bioanalytical services.

“It also allows for customization so we can efficiently meet our client's needs. We want to be able to provide accurate, compliant data in a client specified format as fast as possible”

The Thermo Watson LIMS is the industry Gold Standard for managing bioanalytical data. It is a highly specialized protocol-driven Laboratory Information Management System specifically designed to support DMPK/Bioanalytical studies in drug development.

Growth at Agilux has been fueled by the recognition of its expert bioanalytical capability. With an experienced team of bioanalytical scientists, the latest LC-MS/MS instrumentation, and a commitment to customer service, Agilux Laboratories has the proven track record to solve even the most complex of bioanalytical challenges. Watson enhances this capability and provides a standardized bioanalytical workflow that allows for efficient and compliant sample handling, data processing, and reporting. "It also allows for customization so we can efficiently meet our client's needs. We want to be able to provide accurate, compliant data in a client specified format as fast as possible," said Brian Lilley Sr. Director of GLP Bioanalysis.

"Information technology is a key component in our commitment to lead the industry by producing "Better Data Faster" said Jim Jersey, President and CEO at Agilux, "Watson is a central component of that IT infrastructure."

Source:

Agilux Laboratories Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose